Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Colorectal Neoplasms

Free Subscription Articles published in BMC Cancer Retrieve available abstracts of 237 articles: HTML format Text format

Single Articles

July 2019
1. GAO Y, Nan X, Shi X, Mu X, et al
   SREBP1 promotes the invasion of colorectal cancer accompanied upregulation of MMP7 expression and NF-kappaB pathway activation.
   BMC Cancer. 2019;19:685.
   PubMed     Text format     Abstract available
   
   
   
2. ALWERS E, Blaker H, Walter V, Jansen L, et al
   External validation of molecular subtype classifications of colorectal cancer based on microsatellite instability, CIMP, BRAF and KRAS.
   BMC Cancer. 2019;19:681.
   PubMed     Text format     Abstract available
   
   
   
3. NG TH, Sham KWY, Xie CM, Ng SSM, et al
   Eukaryotic elongation factor-2 kinase expression is an independent prognostic factor in colorectal cancer.
   BMC Cancer. 2019;19:649.
   PubMed     Text format     Abstract available
   
   
   June 2019
4. CAVAGNARI MAV, Silva TD, Pereira MAH, Sauer LJ, et al
   Impact of genetic mutations and nutritional status on the survival of patients with colorectal cancer.
   BMC Cancer. 2019;19:644.
   PubMed     Text format     Abstract available
   
   
   
5. CHEN SH, Tsai HL, Jiang JK, Sung YC, et al
   Emergence of RAS mutations in patients with metastatic colorectal cancer receiving cetuximab-based treatment: a study protocol.
   BMC Cancer. 2019;19:640.
   PubMed     Text format     Abstract available
   
   
   
6. TERAZAWA T, Kato T, Goto M, Sakai D, et al
   First-line single-agent panitumumab in frail elderly patients with wild-type RAS unresectable colorectal cancer: a phase II study protocol OGSG 1602.
   BMC Cancer. 2019;19:623.
   PubMed     Text format     Abstract available
   
   
   
7. SONG Z, Chen E, Qian J, Xu J, et al
   Serum chitinase activity prognosticates metastasis of colorectal cancer.
   BMC Cancer. 2019;19:629.
   PubMed     Text format     Abstract available
   
   
   
8. JIANG Y, Sun Y, Hu J, Yu N, et al
   A germline mutation in Rab43 gene identified from a cancer family predisposes to a hereditary liver-colon cancer syndrome.
   BMC Cancer. 2019;19:613.
   PubMed     Text format     Abstract available
   
   
   
9. WANG H, Wang X, Xu L, Zhang J, et al
   Analysis of the transcriptomic features of microsatellite instability subtype colon cancer.
   BMC Cancer. 2019;19:605.
   PubMed     Text format     Abstract available
   
   
   
10. FENG Y, Qian W, Zhang Y, Peng W, et al
    CDCA2 promotes the proliferation of colorectal cancer cells by activating the AKT/CCND1 pathway in vitro and in vivo.
    BMC Cancer. 2019;19:576.
    PubMed     Text format     Abstract available
    
    
    
11. CALLEBOUT E, Ribeiro SM, Laurent S, De Man M, et al
    Long term response on Regorafenib in non-V600E BRAF mutated colon cancer: a case report.
    BMC Cancer. 2019;19:567.
    PubMed     Text format     Abstract available
    
    
    
12. CARRATO A, Benavides M, Massuti B, Ferreiro-Monteagudo R, et al
    First-line single-agent regorafenib in frail patients with metastatic colorectal cancer: a pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD).
    BMC Cancer. 2019;19:533.
    PubMed     Text format     Abstract available
    
    
    
13. SAIJO S, Kuwano Y, Tange S, Rokutan K, et al
    A novel long non-coding RNA from the HOXA6-HOXA5 locus facilitates colon cancer cell growth.
    BMC Cancer. 2019;19:532.
    PubMed     Text format     Abstract available
    
    
    May 2019
14. ROQUETTE R, Painho M, Nunes B
    Geographical patterns of the incidence and mortality of colorectal cancer in mainland Portugal municipalities (2007-2011).
    BMC Cancer. 2019;19:512.
    PubMed     Text format     Abstract available
    
    
    
15. KIM EG, Kim JO, Park HS, Ryu CS, et al
    Genetic associations between the miRNA polymorphisms miR-130b (rs373001), miR-200b (rs7549819), and miR-495 (rs2281611) and colorectal cancer susceptibility.
    BMC Cancer. 2019;19:480.
    PubMed     Text format     Abstract available
    
    
    
16. WANG F, He MM, Wang ZX, Li S, et al
    Phase I study of high-dose ascorbic acid with mFOLFOX6 or FOLFIRI in patients with metastatic colorectal cancer or gastric cancer.
    BMC Cancer. 2019;19:460.
    PubMed     Text format     Abstract available
    
    
    
17. BURM R, Thewes B, Rodwell L, Kievit W, et al
    Long-term efficacy and cost-effectiveness of blended cognitive behavior therapy for high fear of recurrence in breast, prostate and colorectal Cancer survivors: follow-up of the SWORD randomized controlled trial.
    BMC Cancer. 2019;19:462.
    PubMed     Text format     Abstract available
    
    
    
18. CHEN Z, Wu G, Ye F, Chen G, et al
    High expression of MMP19 is associated with poor prognosis in patients with colorectal cancer.
    BMC Cancer. 2019;19:448.
    PubMed     Text format     Abstract available
    
    
    
19. SUN J, Fei F, Zhang M, Li Y, et al
    The role of (m)SEPT9 in screening, diagnosis, and recurrence monitoring of colorectal cancer.
    BMC Cancer. 2019;19:450.
    PubMed     Text format     Abstract available
    
    
    
20. PENNEY ME, Parfrey PS, Savas S, Yilmaz YE, et al
    Correction to: A genome-wide association study identifies single nucleotide polymorphisms associated with time-to-metastasis in colorectal cancer.
    BMC Cancer. 2019;19:437.
    PubMed     Text format     Abstract available
    
    
    
21. NAKAGAWA-SENDA H, Hori M, Matsuda T, Ito H, et al
    Prognostic impact of tumor location in colon cancer: the Monitoring of Cancer Incidence in Japan (MCIJ) project.
    BMC Cancer. 2019;19:431.
    PubMed     Text format     Abstract available
    
    
    
22. PRIETO SP, Reed CL, James HM, Quinn KP, et al
    Differences in colonic crypt morphology of spontaneous and colitis-associated murine models via second harmonic generation imaging to quantify colon cancer development.
    BMC Cancer. 2019;19:428.
    PubMed     Text format     Abstract available
    
    
    
23. HENDRICKS A, Gieseler F, Nazzal S, Brasen JH, et al
    Prognostic relevance of topoisomerase II alpha and minichromosome maintenance protein 6 expression in colorectal cancer.
    BMC Cancer. 2019;19:429.
    PubMed     Text format     Abstract available
    
    
    
24. LEE DW, Han SW, Cha Y, Bae JM, et al
    Association of pathway mutation with survival after recurrence in colorectal cancer patients treated with adjuvant fluoropyrimidine and oxaliplatin chemotherapy.
    BMC Cancer. 2019;19:421.
    PubMed     Text format     Abstract available
    
    
    
25. HINES RB, Jiban MJH, Specogna AV, Vishnubhotla P, et al
    The association between post-treatment surveillance testing and survival in stage II and III colon cancer patients: An observational comparative effectiveness study.
    BMC Cancer. 2019;19:418.
    PubMed     Text format     Abstract available
    
    
    April 2019
26. DE MESQUITA GHA, Carvalho BJ, de Almeida Medeiros KA, Nii F, et al
    Intussusception reveals MUTYH-associated polyposis syndrome and colorectal cancer: a case report.
    BMC Cancer. 2019;19:324.
    PubMed     Text format     Abstract available
    
    
    
27. WU YY, Zhang X, Qin YY, Qin JQ, et al
    Mean platelet volume/platelet count ratio in colorectal cancer: a retrospective clinical study.
    BMC Cancer. 2019;19:314.
    PubMed     Text format     Abstract available
    
    
    
28. ROTHE F, Maetens M, Rouas G, Paesmans M, et al
    CTCs as a prognostic and predictive biomarker for stage II/III Colon Cancer: a companion study to the PePiTA trial.
    BMC Cancer. 2019;19:304.
    PubMed     Text format     Abstract available
    
    
    
29. GARCIA-TORRECILLAS JM, Olvera-Porcel MC, Ferrer-Marquez M, Rubio-Gil F, et al
    Spatial and temporal variations in Spain in the standardised ratio of in-hospital mortality due to colorectal cancer, 2008-2014.
    BMC Cancer. 2019;19:310.
    PubMed     Text format     Abstract available
    
    
    March 2019
30. SANDBERG TP, Stuart MPME, Oosting J, Tollenaar RAEM, et al
    Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer.
    BMC Cancer. 2019;19:284.
    PubMed     Text format     Abstract available
    
    
    
31. ZHENG B, Wang X, Wei M, Wang Q, et al
    First-line cetuximab versus bevacizumab for RAS and BRAF wild-type metastatic colorectal cancer: a systematic review and meta-analysis.
    BMC Cancer. 2019;19:280.
    PubMed     Text format     Abstract available
    
    
    
32. BOWLES EJA, Yu O, Ziebell R, Chen L, et al
    Cardiovascular medication use and risks of colon cancer recurrences and additional cancer events: a cohort study.
    BMC Cancer. 2019;19:270.
    PubMed     Text format     Abstract available
    
    
    
33. HARADA K, Okamoto W, Mimaki S, Kawamoto Y, et al
    Comparative sequence analysis of patient-matched primary colorectal cancer, metastatic, and recurrent metastatic tumors after adjuvant FOLFOX chemotherapy.
    BMC Cancer. 2019;19:255.
    PubMed     Text format     Abstract available
    
    
    
34. BASTIAENEN VP, Klaver CEL, Kok NFM, de Wilt JHW, et al
    Second and third look laparoscopy in pT4 colon cancer patients for early detection of peritoneal metastases; the COLOPEC 2 randomized multicentre trial.
    BMC Cancer. 2019;19:254.
    PubMed     Text format     Abstract available
    
    
    
35. SHIBUTANI M, Maeda K, Nagahara H, Fukuoka T, et al
    The prognostic significance of the advanced lung cancer inflammation index in patients with unresectable metastatic colorectal cancer: a retrospective study.
    BMC Cancer. 2019;19:241.
    PubMed     Text format     Abstract available
    
    
    
36. VAN BLARIGAN EL, Chan H, Van Loon K, Kenfield SA, et al
    Self-monitoring and reminder text messages to increase physical activity in colorectal cancer survivors (Smart Pace): a pilot randomized controlled trial.
    BMC Cancer. 2019;19:218.
    PubMed     Text format     Abstract available
    
    
    
37. KAZLAUSKAS A, Darinskas A, Meskys R, Tamasauskas A, et al
    Isocytosine deaminase Vcz as a novel tool for the prodrug cancer therapy.
    BMC Cancer. 2019;19:197.
    PubMed     Text format     Abstract available
    
    
    
38. HUMMEL S, Kohlmann W, Kollmeyer TM, Jenkins R, et al
    The contribution of the rs55705857 G allele to familial cancer risk as estimated in the Utah population database.
    BMC Cancer. 2019;19:190.
    PubMed     Text format     Abstract available
    
    
    February 2019
39. JI H, Lu L, Huang J, Liu Y, et al
    IL1A polymorphisms is a risk factor for colorectal cancer in Chinese Han population: a case control study.
    BMC Cancer. 2019;19:181.
    PubMed     Text format     Abstract available
    
    
    
40. TANABE T, Shida D, Tsukamoto S, Morizono G, et al
    Metachronous metastasis to inguinal lymph nodes from sigmoid colon adenocarcinoma with abdominal wall metastasis: a case report.
    BMC Cancer. 2019;19:180.
    PubMed     Text format     Abstract available
    
    
    
41. KLEMENT RJ, Abbasi-Senger N, Adebahr S, Alheid H, et al
    The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases.
    BMC Cancer. 2019;19:173.
    PubMed     Text format     Abstract available
    
    
    
42. WANG Y, Jiang T, Jiang M, Gu S, et al
    Appraising growth differentiation factor 15 as a promising biomarker in digestive system tumors: a meta-analysis.
    BMC Cancer. 2019;19:177.
    PubMed     Text format     Abstract available
    
    
    
43. MJELLE R, Sjursen W, Thommesen L, Saetrom P, et al
    Small RNA expression from viruses, bacteria and human miRNAs in colon cancer tissue and its association with microsatellite instability and tumor location.
    BMC Cancer. 2019;19:161.
    PubMed     Text format     Abstract available
    
    
    
44. CHEN M, Sharma A, Lin Y, Wu Y, et al
    Insluin and epithelial growth factor (EGF) promote programmed death ligand 1(PD-L1) production and transport in colon cancer stem cells.
    BMC Cancer. 2019;19:153.
    PubMed     Text format     Abstract available
    
    
    
45. KHAN OF, Cusano E, Raissouni S, Pabia M, et al
    Immediate-term cognitive impairment following intravenous (IV) chemotherapy: a prospective pre-post design study.
    BMC Cancer. 2019;19:150.
    PubMed     Text format     Abstract available
    
    
    
46. ERIKSEN AC, Sorensen FB, Lindebjerg J, Hager H, et al
    Programmed Death Ligand-1 expression in stage II colon cancer - experiences from a nationwide populationbased cohort.
    BMC Cancer. 2019;19:142.
    PubMed     Text format     Abstract available
    
    
    
47. CHARETTE N, Vandeputte C, Ameye L, Bogaert CV, et al
    Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials.
    BMC Cancer. 2019;19:134.
    PubMed     Text format     Abstract available
    
    
    
48. PENNEY ME, Parfrey PS, Savas S, Yilmaz YE, et al
    A genome-wide association study identifies single nucleotide polymorphisms associated with time-to-metastasis in colorectal cancer.
    BMC Cancer. 2019;19:133.
    PubMed     Text format     Abstract available
    
    
    
49. LUO ZW, Zhu MG, Zhang ZQ, Ye FJ, et al
    Increased expression of Ki-67 is a poor prognostic marker for colorectal cancer patients: a meta analysis.
    BMC Cancer. 2019;19:123.
    PubMed     Text format     Abstract available
    
    
    
50. SCHUURHUIZEN CSEW, Braamse AMJ, Konings IRHM, Verheul HMW, et al
    Predictors for use of psychosocial services in patients with metastatic colorectal cancer receiving first line systemic treatment.
    BMC Cancer. 2019;19:115.
    PubMed     Text format     Abstract available
    
    
    January 2019
51. VAN ROOIJEN S, Carli F, Dalton S, Thomas G, et al
    Multimodal prehabilitation in colorectal cancer patients to improve functional capacity and reduce postoperative complications: the first international randomized controlled trial for multimodal prehabilitation.
    BMC Cancer. 2019;19:98.
    PubMed     Text format     Abstract available
    
    
    
52. CASTELLANO-CASTILLO D, Morcillo S, Crujeiras AB, Sanchez-Alcoholado L, et al
    Association between serum 25-hydroxyvitamin D and global DNA methylation in visceral adipose tissue from colorectal cancer patients.
    BMC Cancer. 2019;19:93.
    PubMed     Text format     Abstract available
    
    
    
53. LI B, Wang Y, Yin L, Huang G, et al
    Glucocorticoids promote the development of azoxymethane and dextran sulfate sodium-induced colorectal carcinoma in mice.
    BMC Cancer. 2019;19:94.
    PubMed     Text format     Abstract available
    
    
    
54. CAI SR, Huang YQ, Zhang SZ, Li QL, et al
    Effects of subitems in the colorectal cancer screening protocol on the Chinese colorectal cancer screening program: an analysis based on natural community screening results.
    BMC Cancer. 2019;19:47.
    PubMed     Text format     Abstract available
    
    
    
55. XIN H, Wang C, Liu Z
    miR-196a-5p promotes metastasis of colorectal cancer via targeting IkappaBalpha.
    BMC Cancer. 2019;19:30.
    PubMed     Text format     Abstract available
    
    
    
56. CHANG J, Lin G, Ye M, Tong D, et al
    Decreased mean platelet volume predicts poor prognosis in metastatic colorectal cancer patients treated with first-line chemotherapy: results from mCRC biomarker study.
    BMC Cancer. 2019;19:15.
    PubMed     Text format     Abstract available
    
    
    December 2018
57. TIAN P, Zhu Y, Zhang C, Guo X, et al
    Ras-ERK1/2 signaling contributes to the development of colorectal cancer via regulating H3K9ac.
    BMC Cancer. 2018;18:1286.
    PubMed     Text format     Abstract available
    
    
    
58. XU Y, Yang X, Gao D, Yang L, et al
    Dihomo-gamma-linolenic acid inhibits xenograft tumor growth in mice bearing shRNA-transfected HCA-7 cells targeting delta-5-desaturase.
    BMC Cancer. 2018;18:1268.
    PubMed     Text format     Abstract available
    
    
    
59. BARRESI V, Cinnirella G, Valenti G, Spampinato G, et al
    Gene expression profiles in genome instability-based classes of colorectal cancer.
    BMC Cancer. 2018;18:1265.
    PubMed     Text format     Abstract available
    
    
    
60. LIN Z, Liu J, Peng L, Zhang D, et al
    Complete pathological response following neoadjuvant FOLFOX chemotherapy in BRCA2-mutant locally advanced rectal cancer: a case report.
    BMC Cancer. 2018;18:1253.
    PubMed     Text format     Abstract available
    
    
    
61. LIU M, Sun W, Cai YY, Wu HZ, et al
    Validation of Quality of Life Instruments for Cancer Patients - Colorectal Cancer (QLICP-CR) in patients with colorectal cancer in Northeast China.
    BMC Cancer. 2018;18:1228.
    PubMed     Text format     Abstract available
    
    
    
62. ALSHERIDAH N, Akhtar S
    Diet, obesity and colorectal carcinoma risk: results from a national cancer registry-based middle-eastern study.
    BMC Cancer. 2018;18:1227.
    PubMed     Text format     Abstract available
    
    
    
63. DEN BAKKER CM, Schaafsma FG, Huirne JAF, Consten ECJ, et al
    Cancer survivors' needs during various treatment phases after multimodal treatment for colon cancer - is there a role for eHealth?
    BMC Cancer. 2018;18:1207.
    PubMed     Text format     Abstract available
    
    
    
64. OYEYEMI SO, Braaten T, Licaj I, Lund E, et al
    Physical activity patterns and the risk of colorectal cancer in the Norwegian Women and Cancer study: a population-based prospective study.
    BMC Cancer. 2018;18:1216.
    PubMed     Text format     Abstract available
    
    
    
65. PETRERA M, Paleari L, Clavarezza M, Puntoni M, et al
    The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2 x 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients.
    BMC Cancer. 2018;18:1210.
    PubMed     Text format     Abstract available
    
    
    
66. FORTEA-SANCHIS C, Martinez-Ramos D, Escrig-Sos J
    The lymph node status as a prognostic factor in colon cancer: comparative population study of classifications using the logarithm of the ratio between metastatic and nonmetastatic nodes (LODDS) versus the pN-TNM classification and ganglion ratio syste
    BMC Cancer. 2018;18:1208.
    PubMed     Text format     Abstract available
    
    
    
67. JANG M, Kwon Y, Kim H, Kim H, et al
    Microsatellite instability test using peptide nucleic acid probe-mediated melting point analysis: a comparison study.
    BMC Cancer. 2018;18:1218.
    PubMed     Text format     Abstract available
    
    
    
68. DIMITRIOU N, Felekouras E, Karavokyros I, Alexandrou A, et al
    Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients.
    BMC Cancer. 2018;18:1202.
    PubMed     Text format     Abstract available
    
    
    November 2018
69. POMPSCH M, Vogel J, Classen F, Kranz P, et al
    The presumed MTH1-inhibitor TH588 sensitizes colorectal carcinoma cells to ionizing radiation in hypoxia.
    BMC Cancer. 2018;18:1190.
    PubMed     Text format     Abstract available
    
    
    
70. RATJEN I, Schafmayer C, Enderle J, di Giuseppe R, et al
    Health-related quality of life in long-term survivors of colorectal cancer and its association with all-cause mortality: a German cohort study.
    BMC Cancer. 2018;18:1156.
    PubMed     Text format     Abstract available
    
    
    
71. CHEN Y, Tan F, Wei L, Li X, et al
    Sleep duration and the risk of cancer: a systematic review and meta-analysis including dose-response relationship.
    BMC Cancer. 2018;18:1149.
    PubMed     Text format     Abstract available
    
    
    
72. YAMAURA M, Yamada T, Watanabe R, Kawai H, et al
    Anal canal adenocarcinoma with neuroendocrine features accompanying secondary extramammary Paget disease, successfully treated with modified FOLFOX6: a case report.
    BMC Cancer. 2018;18:1142.
    PubMed     Text format     Abstract available
    
    
    
73. HU H, Huang J, Lan P, Wang L, et al
    CEA clearance pattern as a predictor of tumor response to neoadjuvant treatment in rectal cancer: a post-hoc analysis of FOWARC trial.
    BMC Cancer. 2018;18:1145.
    PubMed     Text format     Abstract available
    
    
    
74. KASPER S, Kisro J, Fuchs M, Muller C, et al
    Safety profile of trifluridine/tipiracil monotherapy in clinical practice: results of the German compassionate-use program for patients with metastatic colorectal cancer.
    BMC Cancer. 2018;18:1124.
    PubMed     Text format     Abstract available
    
    
    
75. SHARAF LK, Sharma M, Chandel D, Shukla G, et al
    Prophylactic intervention of probiotics (L.acidophilus, L.rhamnosus GG) and celecoxib modulate Bax-mediated apoptosis in 1,2-dimethylhydrazine-induced experimental colon carcinogenesis.
    BMC Cancer. 2018;18:1111.
    PubMed     Text format     Abstract available
    
    
    
76. WANG F, He W, Jiang C, Guo G, et al
    Prognostic value of inflammation-based scores in patients receiving radical resection for colorectal cancer.
    BMC Cancer. 2018;18:1102.
    PubMed     Text format     Abstract available
    
    
    
77. LIU FR, Bai S, Feng Q, Pan XY, et al
    Anti-colorectal cancer effects of anti-p21Ras scFv delivered by the recombinant adenovirus KGHV500 and cytokine-induced killer cells.
    BMC Cancer. 2018;18:1087.
    PubMed     Text format     Abstract available
    
    
    
78. BELLUCO C, Forlin M, Delrio P, Rega D, et al
    Elevated platelet count is a negative predictive and prognostic marker in locally advanced rectal cancer undergoing neoadjuvant chemoradiation: a retrospective multi-institutional study on 965 patients.
    BMC Cancer. 2018;18:1094.
    PubMed     Text format     Abstract available
    
    
    
79. TIAN Y, Li J, Zhou T, Tong D, et al
    Spatially varying effects of predictors for the survival prediction of nonmetastatic colorectal Cancer.
    BMC Cancer. 2018;18:1084.
    PubMed     Text format     Abstract available
    
    
    
80. YU P, Zhou M, Qu J, Fu L, et al
    The dynamic monitoring of CEA in response to chemotherapy and prognosis of mCRC patients.
    BMC Cancer. 2018;18:1076.
    PubMed     Text format     Abstract available
    
    
    
81. ASHKTORAB H, Rahi H, Nouraie M, Shokrani B, et al
    GPNMB methylation: a new marker of potentially carcinogenic colon lesions.
    BMC Cancer. 2018;18:1068.
    PubMed     Text format     Abstract available
    
    
    
82. NAGATA N, Nishijima T, Niikura R, Yokoyama T, et al
    Increased risk of non-AIDS-defining cancers in Asian HIV-infected patients: a long-term cohort study.
    BMC Cancer. 2018;18:1066.
    PubMed     Text format     Abstract available
    
    
    
83. MAHMOOD S, English DR, MacInnis RJ, Karahalios A, et al
    Domain-specific physical activity and the risk of colorectal cancer: results from the Melbourne Collaborative Cohort Study.
    BMC Cancer. 2018;18:1063.
    PubMed     Text format     Abstract available
    
    
    
84. LEE CH, Im EJ, Moon PG, Baek MC, et al
    Discovery of a diagnostic biomarker for colon cancer through proteomic profiling of small extracellular vesicles.
    BMC Cancer. 2018;18:1058.
    PubMed     Text format     Abstract available
    
    
    
85. CRUZ-NOVA P, Schnoor M, Correa-Basurto J, Bello M, et al
    The small organic molecule C19 binds and strengthens the KRAS4b-PDEdelta complex and inhibits growth of colorectal cancer cells in vitro and in vivo.
    BMC Cancer. 2018;18:1056.
    PubMed     Text format     Abstract available
    
    
    October 2018
86. KAERLEV L, Iachina M, Trosko O, Qvist N, et al
    Colon cancer patients with a serious psychiatric disorder present with a more advanced cancer stage and receive less adjuvant chemotherapy - A Nationwide Danish Cohort Study.
    BMC Cancer. 2018;18:1050.
    PubMed     Text format     Abstract available
    
    
    
87. YE X, Mo M, Xu S, Yang Q, et al
    The hypermethylation of p16 gene exon 1 and exon 2: potential biomarkers for colorectal cancer and are associated with cancer pathological staging.
    BMC Cancer. 2018;18:1023.
    PubMed     Text format     Abstract available
    
    
    
88. O'GORMAN C, Stack J, O'Ceilleachair A, Denieffe S, et al
    Colorectal cancer survivors: an investigation of symptom burden and influencing factors.
    BMC Cancer. 2018;18:1022.
    PubMed     Text format     Abstract available
    
    
    
89. ZENG Z, Yang H, Xiao S
    ACTL6A expression promotes invasion, metastasis and epithelial mesenchymal transition of colon cancer.
    BMC Cancer. 2018;18:1020.
    PubMed     Text format     Abstract available
    
    
    
90. PERTTULA K, Schiffman C, Edmands WMB, Petrick L, et al
    Untargeted lipidomic features associated with colorectal cancer in a prospective cohort.
    BMC Cancer. 2018;18:996.
    PubMed     Text format     Abstract available
    
    
    
91. SPERLICH A, Balmert A, Doll D, Bauer S, et al
    Genetic and immunological biomarkers predict metastatic disease recurrence in stage III colon cancer.
    BMC Cancer. 2018;18:998.
    PubMed     Text format     Abstract available
    
    
    
92. SHIGEMATSU Y, Inamura K, Yamamoto N, Mise Y, et al
    Impact of CDX2 expression status on the survival of patients after curative resection for colorectal cancer liver metastasis.
    BMC Cancer. 2018;18:980.
    PubMed     Text format     Abstract available
    
    
    
93. WANG X, Zamdborg L, Ye H, Grills IS, et al
    A matched-pair analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer versus early stage non-small cell lung cancer.
    BMC Cancer. 2018;18:962.
    PubMed     Text format     Abstract available
    
    
    
94. SHI J, Fei J, Yi Q, Shen L, et al
    Treatment of colon cancer in a patient with systemic lupus erythematosus: a case report.
    BMC Cancer. 2018;18:961.
    PubMed     Text format     Abstract available
    
    
    
95. DOTE S, Itakura S, Kamei K, Hira D, et al
    Oral mucositis associated with anti-EGFR therapy in colorectal cancer: single institutional retrospective cohort study.
    BMC Cancer. 2018;18:957.
    PubMed     Text format     Abstract available
    
    
    
96. MIZOTA Y, Kanemitsu Y, Tsukamoto S, Shida D, et al
    ROK study-C (Rainbow of KIBOU study-colorectum): a colorectal cancer survivor cohort study on food, nutrition, physical activity, psychosocial factors and its influences on colorectal cancer recurrence, survival and quality of life in Japan.
    BMC Cancer. 2018;18:953.
    PubMed     Text format     Abstract available
    
    
    
97. CANTERO-CID R, Casas-Martin J, Hernandez-Jimenez E, Cubillos-Zapata C, et al
    PD-L1/PD-1 crosstalk in colorectal cancer: are we targeting the right cells?
    BMC Cancer. 2018;18:945.
    PubMed     Text format     Abstract available
    
    
    September 2018
98. YANG L, Xiong Z, Xie QK, He W, et al
    Second primary colorectal cancer after the initial primary colorectal cancer.
    BMC Cancer. 2018;18:931.
    PubMed     Text format     Abstract available
    
    
    
99. DOS SANTOS JS, Bonafe GA, Pereira JA, Kanno DT, et al
    Rare perianal extramammary Paget disease successfully treated using topical Imiquimod therapy.
    BMC Cancer. 2018;18:921.
    PubMed     Text format     Abstract available
    
    
    
100. TIKK K, Czock D, Haefeli WE, Kopp-Schneider A, et al
     Clinical trial protocol of the ASTER trial: a double-blind, randomized, placebo-controlled phase III trial evaluating the use of acetylsalicylic acid (ASA) for enhanced early detection of colorectal neoplasms.
     BMC Cancer. 2018;18:914.
     PubMed     Text format     Abstract available
     
     
     
101. WHITE A, Ironmonger L, Steele RJC, Ormiston-Smith N, et al
     A review of sex-related differences in colorectal cancer incidence, screening uptake, routes to diagnosis, cancer stage and survival in the UK.
     BMC Cancer. 2018;18:906.
     PubMed     Text format     Abstract available
     
     
     
102. LI N, Zhou W, Zhao L, Zhou J, et al
     Endometriosis-associated recto-sigmoid cancer: a case report.
     BMC Cancer. 2018;18:905.
     PubMed     Text format     Abstract available
     
     
     
103. SEIDENSTICKER R, Damm R, Enge J, Seidensticker M, et al
     Local ablation or radioembolization of colorectal cancer metastases: comorbidities or older age do not affect overall survival.
     BMC Cancer. 2018;18:882.
     PubMed     Text format     Abstract available
     
     
     
104. SCHLIEMANN D, Donnelly M, Dahlui M, Loh SY, et al
     The 'Be Cancer Alert Campaign': protocol to evaluate a mass media campaign to raise awareness about breast and colorectal cancer in Malaysia.
     BMC Cancer. 2018;18:881.
     PubMed     Text format     Abstract available
     
     
     
105. MENDEZ LC, Hsieh E, Earle CC, Wong S, et al
     Synchronous anal canal carcinoma in a heterosexual couple.
     BMC Cancer. 2018;18:884.
     PubMed     Text format     Abstract available
     
     
     
106. HO V, Chung L, Singh A, Lea V, et al
     Overexpression of the MRE11-RAD50-NBS1 (MRN) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis.
     BMC Cancer. 2018;18:869.
     PubMed     Text format     Abstract available
     
     
     August 2018
107. DURINIKOVA E, Kozovska Z, Poturnajova M, Plava J, et al
     ALDH1A3 upregulation and spontaneous metastasis formation is associated with acquired chemoresistance in colorectal cancer cells.
     BMC Cancer. 2018;18:848.
     PubMed     Text format     Abstract available
     
     
     
108. LUALDI M, Cavalleri A, Battaglia L, Colombo A, et al
     Early detection of colorectal adenocarcinoma: a clinical decision support tool based on plasma porphyrin accumulation and risk factors.
     BMC Cancer. 2018;18:841.
     PubMed     Text format     Abstract available
     
     
     
109. SUN X, Ju T, Cummings RD
     Differential expression of Cosmc, T-synthase and mucins in Tn-positive colorectal cancers.
     BMC Cancer. 2018;18:827.
     PubMed     Text format     Abstract available
     
     
     
110. SABER MM, Al-Mahallawi AM, Nassar NN, Stork B, et al
     Targeting colorectal cancer cell metabolism through development of cisplatin and metformin nano-cubosomes.
     BMC Cancer. 2018;18:822.
     PubMed     Text format     Abstract available
     
     
     
111. PUIJK RS, Ruarus AH, Vroomen LGPH, van Tilborg AAJM, et al
     Colorectal liver metastases: surgery versus thermal ablation (COLLISION) - a phase III single-blind prospective randomized controlled trial.
     BMC Cancer. 2018;18:821.
     PubMed     Text format     Abstract available
     
     
     
112. RUDERMAN S, Eshein A, Valuckaite V, Dougherty U, et al
     Early increase in blood supply (EIBS) is associated with tumor risk in the Azoxymethane model of colon cancer.
     BMC Cancer. 2018;18:814.
     PubMed     Text format     Abstract available
     
     
     
113. TOSI D, Perez-Gracia E, Atis S, Vie N, et al
     Rational development of synergistic combinations of chemotherapy and molecular targeted agents for colorectal cancer treatment.
     BMC Cancer. 2018;18:812.
     PubMed     Text format     Abstract available
     
     
     
114. LAN L, Liu H, Smith AR, Appelman C, et al
     Natural product derivative Gossypolone inhibits Musashi family of RNA-binding proteins.
     BMC Cancer. 2018;18:809.
     PubMed     Text format     Abstract available
     
     
     
115. REDMOND HP, Neary PM, Jinih M, O'Connell E, et al
     RandomiSed clinical trial assessing Use of an anti-inflammatoRy aGent in attenUating peri-operatiVe inflAmmatioN in non-meTastatic colon cancer - the S.U.R.G.U.V.A.N.T. trial.
     BMC Cancer. 2018;18:794.
     PubMed     Text format     Abstract available
     
     
     
116. LI N, Chen M, Cao Y, Li H, et al
     Bcl-2-associated athanogene 3(BAG3) is associated with tumor cell proliferation, migration, invasion and chemoresistance in colorectal cancer.
     BMC Cancer. 2018;18:793.
     PubMed     Text format     Abstract available
     
     
     
117. GOERE D, Pignon JP, Gelli M, Elias D, et al
     Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).
     BMC Cancer. 2018;18:787.
     PubMed     Text format     Abstract available
     
     
     
118. KORDOWSKI F, Kolarova J, Schafmayer C, Buch S, et al
     Aberrant DNA methylation of ADAMTS16 in colorectal and other epithelial cancers.
     BMC Cancer. 2018;18:796.
     PubMed     Text format     Abstract available
     
     
     July 2018
119. CHIU KWH, Lam KO, An H, Cheung GTC, et al
     Long-term outcomes and recurrence pattern of 18F-FDG PET-CT complete metabolic response in the first-line treatment of metastatic colorectal cancer: a lesion-based and patient-based analysis.
     BMC Cancer. 2018;18:776.
     PubMed     Text format     Abstract available
     
     
     
120. MOGENSEN MB, Rossing M, Ostrup O, Larsen PN, et al
     Genomic alterations accompanying tumour evolution in colorectal cancer: tracking the differences between primary tumours and synchronous liver metastases by whole-exome sequencing.
     BMC Cancer. 2018;18:752.
     PubMed     Text format     Abstract available
     
     
     
121. LEERMAKERS L, Doking S, Thewes B, Braamse AMJ, et al
     Study protocol of the CORRECT multicenter trial: the efficacy of blended cognitive behavioral therapy for reducing psychological distress in colorectal cancer survivors.
     BMC Cancer. 2018;18:748.
     PubMed     Text format     Abstract available
     
     
     
122. TIKK K, Weigl K, Hoffmeister M, Igel S, et al
     Study protocol of the RaPS study: novel risk adapted prevention strategies for people with a family history of colorectal cancer.
     BMC Cancer. 2018;18:720.
     PubMed     Text format     Abstract available
     
     
     June 2018
123. MOLNAR B, Galamb O, Peterfia B, Wichmann B, et al
     Gene promoter and exon DNA methylation changes in colon cancer development - mRNA expression and tumor mutation alterations.
     BMC Cancer. 2018;18:695.
     PubMed     Text format     Abstract available
     
     
     
124. YOUNG EL, Thompson BA, Neklason DW, Firpo MA, et al
     Pancreatic cancer as a sentinel for hereditary cancer predisposition.
     BMC Cancer. 2018;18:697.
     PubMed     Text format     Abstract available
     
     
     
125. CRESPO A, Garcia-Suarez O, Fernandez-Vega I, Solis-Hernandez MP, et al
     Heparan sulfate proteoglycans undergo differential expression alterations in left sided colorectal cancer, depending on their metastatic character.
     BMC Cancer. 2018;18:687.
     PubMed     Text format     Abstract available
     
     
     
126. BOCKELMAN C, Beilmann-Lehtonen I, Kaprio T, Koskensalo S, et al
     Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer.
     BMC Cancer. 2018;18:679.
     PubMed     Text format     Abstract available
     
     
     
127. NEILSEN BK, Chakraborty B, McCall JL, Frodyma DE, et al
     WDR5 supports colon cancer cells by promoting methylation of H3K4 and suppressing DNA damage.
     BMC Cancer. 2018;18:673.
     PubMed     Text format     Abstract available
     
     
     
128. KOZOVSKA Z, Patsalias A, Bajzik V, Durinikova E, et al
     ALDH1A inhibition sensitizes colon cancer cells to chemotherapy.
     BMC Cancer. 2018;18:656.
     PubMed     Text format     Abstract available
     
     
     
129. PANATO C, Abusamaan K, Bidoli E, Hamdi-Cherif M, et al
     Survival after the diagnosis of breast or colorectal cancer in the GAZA Strip from 2005 to 2014.
     BMC Cancer. 2018;18:632.
     PubMed     Text format     Abstract available
     
     
     
130. GUAN X, Wang Y, Hu H, Zhao Z, et al
     Reconsideration of the optimal minimum lymph node count for young colon cancer patients: a population-based study.
     BMC Cancer. 2018;18:623.
     PubMed     Text format     Abstract available
     
     
     May 2018
131. VANIA L, Rebelo TM, Ferreira E, Weiss SFT, et al
     Knock-down of LRP/LR promotes apoptosis in early and late stage colorectal carcinoma cells via caspase activation.
     BMC Cancer. 2018;18:602.
     PubMed     Text format     Abstract available
     
     
     
132. KIM SC, Shin YK, Kim YA, Jang SG, et al
     Identification of genes inducing resistance to ionizing radiation in human rectal cancer cell lines: re-sensitization of radio-resistant rectal cancer cells through down regulating NDRG1.
     BMC Cancer. 2018;18:594.
     PubMed     Text format     Abstract available
     
     
     
133. GONG X, Chen Z, Han Q, Chen C, et al
     Sanguinarine triggers intrinsic apoptosis to suppress colorectal cancer growth through disassociation between STRAP and MELK.
     BMC Cancer. 2018;18:578.
     PubMed     Text format     Abstract available
     
     
     
134. PRICOLO VE, Bonvini M, Abelli CF
     Patterns of care for anal cancer in the United States - a comparison between academic and community cancer centers.
     BMC Cancer. 2018;18:567.
     PubMed     Text format     Abstract available
     
     
     
135. YANG L, Xiong Z, Xie Q, He W, et al
     Prognostic value of total number of lymph nodes retrieved differs between left-sided colon cancer and right-sided colon cancer in stage III patients with colon cancer.
     BMC Cancer. 2018;18:558.
     PubMed     Text format     Abstract available
     
     
     
136. DE-MASI A, Davis E, Cuming T, Chindawi N, et al
     The acceptability of high resolution anoscopy examination in patients attending a tertiary referral centre.
     BMC Cancer. 2018;18:554.
     PubMed     Text format     Abstract available
     
     
     
137. SHULDINER J, Liu Y, Lofters A
     Incidence of breast and colorectal cancer among immigrants in Ontario, Canada: a retrospective cohort study from 2004-2014.
     BMC Cancer. 2018;18:537.
     PubMed     Text format     Abstract available
     
     
     
138. KIM CW, Kang BM, Kim IY, Kim JY, et al
     Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
     BMC Cancer. 2018;18:538.
     PubMed     Text format     Abstract available
     
     
     
139. RUHL R, Rana S, Kelley K, Espinosa-Diez C, et al
     microRNA-451a regulates colorectal cancer proliferation in response to radiation.
     BMC Cancer. 2018;18:517.
     PubMed     Text format     Abstract available
     
     
     
140. REYNOLDS LM, Bissett IP, Consedine NS
     Emotional predictors of bowel screening: the avoidance-promoting role of fear, embarrassment, and disgust.
     BMC Cancer. 2018;18:518.
     PubMed     Text format     Abstract available
     
     
     
141. DI GIROLAMO C, Walters S, Benitez Majano S, Rachet B, et al
     Characteristics of patients with missing information on stage: a population-based study of patients diagnosed with colon, lung or breast cancer in England in 2013.
     BMC Cancer. 2018;18:492.
     PubMed     Text format     Abstract available
     
     
     
142. LILES EG, Perrin N, Rosales AG, Smith DH, et al
     Performance of a quantitative fecal immunochemical test for detecting advanced colorectal neoplasia: a prospective cohort study.
     BMC Cancer. 2018;18:509.
     PubMed     Text format     Abstract available
     
     
     April 2018
143. MEI Z, Shao YW, Lin P, Cai X, et al
     SMAD4 and NF1 mutations as potential biomarkers for poor prognosis to cetuximab-based therapy in Chinese metastatic colorectal cancer patients.
     BMC Cancer. 2018;18:479.
     PubMed     Text format     Abstract available
     
     
     
144. FORSTER I, Brockmann M, Schildgen O, Schildgen V, et al
     Microsatellite instability testing in colorectal cancer using the QiaXcel advanced platform.
     BMC Cancer. 2018;18:484.
     PubMed     Text format     Abstract available
     
     
     
145. HEALY MA, Morris AM, Abrahamse P, Ward KC, et al
     The accuracy of chemotherapy ascertainment among colorectal cancer patients in the surveillance, epidemiology, and end results registry program.
     BMC Cancer. 2018;18:481.
     PubMed     Text format     Abstract available
     
     
     
146. ZICHI C, Tampellini M, Tucci M, Sonetto C, et al
     FOLFOX activity in a rare case of metastatic colonic adenocarcinoma of the tongue: a case report.
     BMC Cancer. 2018;18:470.
     PubMed     Text format     Abstract available
     
     
     
147. BRONZWAER MES, Greuter MJE, Bleijenberg AGC, IJspeert JEG, et al
     Impact of differences in adenoma and proximal serrated polyp detection rate on the long-term effectiveness of FIT-based colorectal cancer screening.
     BMC Cancer. 2018;18:465.
     PubMed     Text format     Abstract available
     
     
     
148. ARROSPIDE A, Idigoras I, Mar J, de Koning H, et al
     Cost-effectiveness and budget impact analyses of a colorectal cancer screening programme in a high adenoma prevalence scenario using MISCAN-Colon microsimulation model.
     BMC Cancer. 2018;18:464.
     PubMed     Text format     Abstract available
     
     
     
149. MUNKER S, Gerken M, Fest P, Ott C, et al
     Chemotherapy for metastatic colon cancer: No effect on survival when the dose is reduced due to side effects.
     BMC Cancer. 2018;18:455.
     PubMed     Text format     Abstract available
     
     
     
150. MENG H, Li W, Boardman LA, Wang L, et al
     Loss of ZG16 is associated with molecular and clinicopathological phenotypes of colorectal cancer.
     BMC Cancer. 2018;18:433.
     PubMed     Text format     Abstract available
     
     
     
151. FANG HJ, Shan SB, Zhou YH, Zhong LY, et al
     Diabetes mellitus and the risk of gastrointestinal cancer in women compared with men: a meta-analysis of cohort studies.
     BMC Cancer. 2018;18:422.
     PubMed     Text format     Abstract available
     
     
     
152. GAUTHE M, Richard-Molard M, Rigault E, Buecher B, et al
     Prognostic value of serum CYFRA 21-1 1 in patients with anal canal squamous cell carcinoma treated with radio(chemo)therapy.
     BMC Cancer. 2018;18:417.
     PubMed     Text format     Abstract available
     
     
     
153. SHINOZAKI E, Tanabe K, Akiyoshi T, Tsuchida T, et al
     Serum leucine-rich alpha-2-glycoprotein-1 with fucosylated triantennary N-glycan: a novel colorectal cancer marker.
     BMC Cancer. 2018;18:406.
     PubMed     Text format     Abstract available
     
     
     
154. SORIANO LC, Soriano-Gabarro M, Garcia Rodriguez LA
     Trends in the contemporary incidence of colorectal cancer and patient characteristics in the United Kingdom: a population-based cohort study using The Health Improvement Network.
     BMC Cancer. 2018;18:402.
     PubMed     Text format     Abstract available
     
     
     
155. DA COSTA PLN, Wynne D, Fifis T, Nguyen L, et al
     The kallikrein-Kinin system modulates the progression of colorectal liver metastases in a mouse model.
     BMC Cancer. 2018;18:382.
     PubMed     Text format     Abstract available
     
     
     
156. WANG H, Chen X, Liu H, Mou T, et al
     Laparoscopy-assisted colectomy as an Oncologically safe alternative for patients with stage T4 Colon Cancer: a propensity-matched cohort study.
     BMC Cancer. 2018;18:370.
     PubMed     Text format     Abstract available
     
     
     
157. SHIBUTANI M, Maeda K, Nagahara H, Fukuoka T, et al
     A comparison of the local immune status between the primary and metastatic tumor in colorectal cancer: a retrospective study.
     BMC Cancer. 2018;18:371.
     PubMed     Text format     Abstract available
     
     
     
158. SANDRA-PETRESCU F, Herrle F, Burkholder I, Kienle P, et al
     Influence of complete administration of adjuvant chemotherapy cycles on overall and disease-free survival in locally advanced rectal cancer: post hoc analysis of a randomized, multicenter, non-inferiority, phase 3 trial.
     BMC Cancer. 2018;18:369.
     PubMed     Text format     Abstract available
     
     
     
159. SHIN HY, Suh M, Choi KS, Hwang SH, et al
     Higher satisfaction with an alternative collection device for stool sampling in colorectal cancer screening with fecal immunochemical test: a cross-sectional study.
     BMC Cancer. 2018;18:365.
     PubMed     Text format     Abstract available
     
     
     
160. SHEN MH, Chen LP, Ho TF, Shih YY, et al
     Validation of the Taiwan Chinese version of the EORTC QLQ-CR29 to assess quality of life in colorectal cancer patients.
     BMC Cancer. 2018;18:353.
     PubMed     Text format     Abstract available
     
     
     March 2018
161. SHIDA D, Ahiko Y, Tanabe T, Yoshida T, et al
     Shorter survival in adolescent and young adult patients, compared to adult patients, with stage IV colorectal cancer in Japan.
     BMC Cancer. 2018;18:334.
     PubMed     Text format     Abstract available
     
     
     
162. HAMASHIMA C, Sano H
     Association between age factors and strategies for promoting participation in gastric and colorectal cancer screenings.
     BMC Cancer. 2018;18:345.
     PubMed     Text format     Abstract available
     
     
     
163. YOUNG JM, Durcinoska I, DeLoyde K, Solomon MJ, et al
     Patterns of follow up and survivorship care for people with colorectal cancer in new South Wales, Australia: a population-based survey.
     BMC Cancer. 2018;18:339.
     PubMed     Text format     Abstract available
     
     
     
164. HUANG EY, Chang JC, Chen HH, Hsu CY, et al
     Carcinoembryonic antigen as a marker of radioresistance in colorectal cancer: a potential role of macrophages.
     BMC Cancer. 2018;18:321.
     PubMed     Text format     Abstract available
     
     
     
165. BUROCK S, Daum S, Keilholz U, Neumann K, et al
     Phase II trial to investigate the safety and efficacy of orally applied niclosamide in patients with metachronous or sychronous metastases of a colorectal cancer progressing after therapy: the NIKOLO trial.
     BMC Cancer. 2018;18:297.
     PubMed     Text format     Abstract available
     
     
     
166. TAI LH, Ananth AA, Seth R, Alkayyal A, et al
     Sepsis increases perioperative metastases in a murine model.
     BMC Cancer. 2018;18:277.
     PubMed     Text format     Abstract available
     
     
     
167. GAO P, Huang XZ, Song YX, Sun JX, et al
     Impact of timing of adjuvant chemotherapy on survival in stage III colon cancer: a population-based study.
     BMC Cancer. 2018;18:234.
     PubMed     Text format     Abstract available
     
     
     
168. EL KINANY K, Deoula M, Hatime Z, Bennani B, et al
     Dairy products and colorectal cancer in middle eastern and north African countries: a systematic review.
     BMC Cancer. 2018;18:233.
     PubMed     Text format     Abstract available
     
     
     February 2018
169. GRAY RT, Coleman HG, Hughes C, Murray LJ, et al
     Low-dose aspirin use and survival in colorectal cancer: results from a population-based cohort study.
     BMC Cancer. 2018;18:228.
     PubMed     Text format     Abstract available
     
     
     
170. STRAINIENE E, Binkis M, Urnikyte S, Stankevicius V, et al
     Microenvironment dependent gene expression signatures in reprogrammed human colon normal and cancer cell lines.
     BMC Cancer. 2018;18:222.
     PubMed     Text format     Abstract available
     
     
     
171. KOWALCZYK M, Orlowski M, Siermontowski P, Mucha D, et al
     Occurrence of colorectal aberrant crypt foci depending on age and dietary patterns of patients.
     BMC Cancer. 2018;18:213.
     PubMed     Text format     Abstract available
     
     
     
172. WANG T, Ning K, Sun X, Zhang C, et al
     Glycolysis is essential for chemoresistance induced by transient receptor potential channel C5 in colorectal cancer.
     BMC Cancer. 2018;18:207.
     PubMed     Text format     Abstract available
     
     
     
173. HEUBLEIN S, Albertsmeier M, Pfeifer D, Loehrs L, et al
     Association of differential miRNA expression with hepatic vs. peritoneal metastatic spread in colorectal cancer.
     BMC Cancer. 2018;18:201.
     PubMed     Text format     Abstract available
     
     
     
174. ARJONA-SANCHEZ A, Barrios P, Boldo-Roda E, Camps B, et al
     HIPECT4: multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic intra-peritoneal chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma.
     BMC Cancer. 2018;18:183.
     PubMed     Text format     Abstract available
     
     
     
175. ZHU Y, Wang PP, Zhai G, Bapat B, et al
     Association of rs2282679 A>C polymorphism in vitamin D binding protein gene with colorectal cancer risk and survival: effect modification by dietary vitamin D intake.
     BMC Cancer. 2018;18:155.
     PubMed     Text format     Abstract available
     
     
     
176. RICHTER J, Kretz AL, Lemke J, Fauler M, et al
     CK1alpha overexpression correlates with poor survival in colorectal cancer.
     BMC Cancer. 2018;18:140.
     PubMed     Text format     Abstract available
     
     
     
177. MARTINEZ-USEROS J, Moreno I, Fernandez-Acenero MJ, Rodriguez-Remirez M, et al
     The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer.
     BMC Cancer. 2018;18:144.
     PubMed     Text format     Abstract available
     
     
     
178. KLAUCK PJ, Bagby SM, Capasso A, Bradshaw-Pierce EL, et al
     Antitumor activity of the polo-like kinase inhibitor, TAK-960, against preclinical models of colorectal cancer.
     BMC Cancer. 2018;18:136.
     PubMed     Text format     Abstract available
     
     
     
179. OZAKI Y, Shindoh J, Gonoi W, Nishioka Y, et al
     Changes in CT morphology can be an independent response marker for patients receiving regorafenib for colorectal liver metastases: retrospective pilot study.
     BMC Cancer. 2018;18:138.
     PubMed     Text format     Abstract available
     
     
     January 2018
180. BATTAGLIN F, Schirripa M, Buggin F, Pietrantonio F, et al
     The PANDA study: a randomized phase II study of first-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS and BRAF wild-type elderly metastatic colorectal cancer patients.
     BMC Cancer. 2018;18:98.
     PubMed     Text format     Abstract available
     
     
     
181. BUSCH EL, Don PK, Chu H, Richardson DB, et al
     Diagnostic accuracy and prediction increment of markers of epithelial-mesenchymal transition to assess cancer cell detachment from primary tumors.
     BMC Cancer. 2018;18:82.
     PubMed     Text format     Abstract available
     
     
     
182. ENGSTRAND J, Nilsson H, Stromberg C, Jonas E, et al
     Colorectal cancer liver metastases - a population-based study on incidence, management and survival.
     BMC Cancer. 2018;18:78.
     PubMed     Text format     Abstract available
     
     
     
183. WANG X, Chen J, Wang J, Yu F, et al
     Correction to: Metalloproteases meprin-a (MEP1A) is a prognostic biomarker and promotes proliferation and invasion of colorectal cancer.
     BMC Cancer. 2018;18:70.
     PubMed     Text format     Abstract available
     
     
     
184. SHAW E, Farris MS, Stone CR, Derksen JWG, et al
     Effects of physical activity on colorectal cancer risk among family history and body mass index subgroups: a systematic review and meta-analysis.
     BMC Cancer. 2018;18:71.
     PubMed     Text format     Abstract available
     
     
     
185. KONG X, Li J, Cai Y, Tian Y, et al
     A modified TNM staging system for non-metastatic colorectal cancer based on nomogram analysis of SEER database.
     BMC Cancer. 2018;18:50.
     PubMed     Text format     Abstract available
     
     
     
186. DAVIS MM, Freeman M, Shannon J, Coronado GD, et al
     A systematic review of clinic and community intervention to increase fecal testing for colorectal cancer in rural and low-income populations in the United States - How, what and when?
     BMC Cancer. 2018;18:40.
     PubMed     Text format     Abstract available
     
     
     
187. HERNANDEZ RK, Wade SW, Reich A, Pirolli M, et al
     Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States.
     BMC Cancer. 2018;18:44.
     PubMed     Text format     Abstract available
     
     
     
188. GU MJ, Huang QC, Bao CZ, Li YJ, et al
     Attributable causes of colorectal cancer in China.
     BMC Cancer. 2018;18:38.
     PubMed     Text format     Abstract available
     
     
     
189. FENNELL LJ, Jamieson S, McKeone D, Corish T, et al
     MLH1-93 G/a polymorphism is associated with MLH1 promoter methylation and protein loss in dysplastic sessile serrated adenomas with BRAF(V600E) mutation.
     BMC Cancer. 2018;18:35.
     PubMed     Text format     Abstract available
     
     
     
190. DEPCZYNSKI J, Dobbins T, Armstrong B, Lower T, et al
     Comparison of cancer incidence in Australian farm residents 45 years and over, compared to rural non-farm and urban residents - a data linkage study.
     BMC Cancer. 2018;18:33.
     PubMed     Text format     Abstract available
     
     
     
191. FARSHIDFAR F, Kopciuk KA, Hilsden R, McGregor SE, et al
     A quantitative multimodal metabolomic assay for colorectal cancer.
     BMC Cancer. 2018;18:26.
     PubMed     Text format     Abstract available
     
     
     
192. ARAKAWA K, Hata K, Yamamoto Y, Nishikawa T, et al
     Nine primary malignant neoplasms-involving the esophagus, stomach, colon, rectum, prostate, and external ear canal-without microsatellite instability: a case report.
     BMC Cancer. 2018;18:24.
     PubMed     Text format     Abstract available
     
     
     
193. HUEMER F, Thaler J, Piringer G, Hackl H, et al
     Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentose Tumortherapie).
     BMC Cancer. 2018;18:11.
     PubMed     Text format     Abstract available
     
     
     December 2017
194. ZHANG K, Wang Y, Yu X, Shi Y, et al
     Recombinant human endostatin combined with radiotherapy inhibits colorectal cancer growth.
     BMC Cancer. 2017;17:899.
     PubMed     Text format     Abstract available
     
     
     
195. FALKOWSKI S, Woillard JB, Postil D, Tubiana-Mathieu N, et al
     Common variants in glucuronidation enzymes and membrane transporters as potential risk factors for colorectal cancer: a case control study.
     BMC Cancer. 2017;17:901.
     PubMed     Text format     Abstract available
     
     
     
196. SONG N, Shin A, Jung HS, Oh JH, et al
     Effects of interactions between common genetic variants and smoking on colorectal cancer.
     BMC Cancer. 2017;17:869.
     PubMed     Text format     Abstract available
     
     
     
197. SHIN HY, Suh M, Park B, Jun JK, et al
     Perceptions of colorectal cancer screening and recommendation behaviors among physicians in Korea.
     BMC Cancer. 2017;17:860.
     PubMed     Text format     Abstract available
     
     
     
198. YEH YS, Chang YT, Ma CJ, Huang CW, et al
     First-decade patient with colorectal cancer carrying both germline and somatic mutations in APC gene.
     BMC Cancer. 2017;17:849.
     PubMed     Text format     Abstract available
     
     
     
199. CAO B, Luo L, Feng L, Ma S, et al
     A network-based predictive gene-expression signature for adjuvant chemotherapy benefit in stage II colorectal cancer.
     BMC Cancer. 2017;17:844.
     PubMed     Text format     Abstract available
     
     
     
200. BEEBE-DIMMER JL, Yee C, Paskett E, Schwartz AG, et al
     Family history of prostate and colorectal cancer and risk of colorectal cancer in the Women's health initiative.
     BMC Cancer. 2017;17:848.
     PubMed     Text format     Abstract available
     
     
     
201. LEE J, Xiao YY, Sun YY, Balderacchi J, et al
     Prevalence and characteristics of hereditary non-polyposis colorectal cancer (HNPCC) syndrome in immigrant Asian colorectal cancer patients.
     BMC Cancer. 2017;17:843.
     PubMed     Text format     Abstract available
     
     
     
202. VULCAN A, Manjer J, Ohlsson B
     High blood glucose levels are associated with higher risk of colon cancer in men: a cohort study.
     BMC Cancer. 2017;17:842.
     PubMed     Text format     Abstract available
     
     
     
203. COELHO H, Jones-Hughes T, Snowsill T, Briscoe S, et al
     A systematic review of test accuracy studies evaluating molecular micro-satellite instability testing for the detection of individuals with lynch syndrome.
     BMC Cancer. 2017;17:836.
     PubMed     Text format     Abstract available
     
     
     
204. BENEDICTO A, Marquez J, Herrero A, Olaso E, et al
     Decreased expression of the beta2 integrin on tumor cells is associated with a reduction in liver metastasis of colorectal cancer in mice.
     BMC Cancer. 2017;17:827.
     PubMed     Text format     Abstract available
     
     
     
205. ZHOU P, Wang C, Hu Z, Chen W, et al
     Genistein induces apoptosis of colon cancer cells by reversal of epithelial-to-mesenchymal via a Notch1/NF-kappaB/slug/E-cadherin pathway.
     BMC Cancer. 2017;17:813.
     PubMed     Text format     Abstract available
     
     
     November 2017
206. HAN VAN KRIEKEN J, Kafatos G, Bennett J, Mineur L, et al
     Panitumumab use in metastatic colorectal cancer and patterns of RAS testing: results from a Europe-wide physician survey and medical records review.
     BMC Cancer. 2017;17:798.
     PubMed     Text format     Abstract available
     
     
     
207. YANG J, Du XL, Li S, Wu Y, et al
     The risk and survival outcome of subsequent primary colorectal cancer after the first primary colorectal cancer: cases from 1973 to 2012.
     BMC Cancer. 2017;17:783.
     PubMed     Text format     Abstract available
     
     
     
208. THIEBAULT Q, Defossez G, Karayan-Tapon L, Ingrand P, et al
     Analysis of factors influencing molecular testing at diagnostic of colorectal cancer.
     BMC Cancer. 2017;17:765.
     PubMed     Text format     Abstract available
     
     
     
209. STEVANATO FILHO PR, Aguiar Junior S, Begnami MD, Kuasne H, et al
     Oestrogen receptor beta isoform expression in sporadic colorectal cancer, familial adenomatous polyposis and progressive stages of colorectal cancer.
     BMC Cancer. 2017;17:754.
     PubMed     Text format     Abstract available
     
     
     
210. SONG Y, Yang Y, Gao P, Chen X, et al
     The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer.
     BMC Cancer. 2017;17:744.
     PubMed     Text format     Abstract available
     
     
     
211. ALONSO-MOLERO J, Gonzalez-Donquiles C, Fernandez-Villa T, de Souza-Teixeira F, et al
     Alterations in PGC1alpha expression levels are involved in colorectal cancer risk: a qualitative systematic review.
     BMC Cancer. 2017;17:731.
     PubMed     Text format     Abstract available
     
     
     
212. ERNST J, Mehnert A, Dietz A, Hornemann B, et al
     Perceived stigmatization and its impact on quality of life - results from a large register-based study including breast, colon, prostate and lung cancer patients.
     BMC Cancer. 2017;17:741.
     PubMed     Text format     Abstract available
     
     
     
213. TAKAHASHI H, Takahashi M, Ohnuma S, Unno M, et al
     microRNA-193a-3p is specifically down-regulated and acts as a tumor suppressor in BRAF-mutated colorectal cancer.
     BMC Cancer. 2017;17:723.
     PubMed     Text format     Abstract available
     
     
     
214. YANG C, Zou K, Zheng L, Xiong B, et al
     Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
     BMC Cancer. 2017;17:725.
     PubMed     Text format     Abstract available
     
     
     
215. YU X, Mi L, Dong J, Zou J, et al
     Long intergenic non-protein-coding RNA 1567 (LINC01567) acts as a "sponge" against microRNA-93 in regulating the proliferation and tumorigenesis of human colon cancer stem cells.
     BMC Cancer. 2017;17:716.
     PubMed     Text format     Abstract available
     
     
     October 2017
216. STEVENS JR, Herrick JS, Wolff RK, Slattery ML, et al
     Identifying factors associated with the direction and significance of microRNA tumor-normal expression differences in colorectal cancer.
     BMC Cancer. 2017;17:707.
     PubMed     Text format     Abstract available
     
     
     
217. RATJEN I, Schafmayer C, di Giuseppe R, Waniek S, et al
     Postdiagnostic physical activity, sleep duration, and TV watching and all-cause mortality among long-term colorectal cancer survivors: a prospective cohort study.
     BMC Cancer. 2017;17:701.
     PubMed     Text format     Abstract available
     
     
     
218. UNGARI AQ, Pereira LRL, Nunes AA, Peria FM, et al
     Cost-effectiveness analysis of XELOX versus XELOX plus bevacizumab for metastatic colorectal cancer in a public hospital school.
     BMC Cancer. 2017;17:691.
     PubMed     Text format     Abstract available
     
     
     August 2017
219. PARK SM, Lee J, Kim YA, Chang YJ, et al
     Factors related with colorectal and stomach cancer screening practice among disease-free lung cancer survivors in Korea.
     BMC Cancer. 2017;17:600.
     PubMed     Text format     Abstract available
     
     
     June 2017
220. COEN M, Rigamonti F, Roth A, Koessler T, et al
     Chemotherapy-induced Takotsubo cardiomyopathy, a case report and review of the literature.
     BMC Cancer. 2017;17:394.
     PubMed     Text format     Abstract available
     
     
     May 2017
221. DARWANTO A, Hein AM, Strauss S, Kong Y, et al
     Use of the QIAGEN GeneReader NGS system for detection of KRAS mutations, validated by the QIAGEN Therascreen PCR kit and alternative NGS platform.
     BMC Cancer. 2017;17:358.
     PubMed     Text format     Abstract available
     
     
     
222. DE FELICE F, Benevento I, Magnante AL, Musio D, et al
     Clinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a meta-analysis : Oxaliplatin in neoadjuvant treatment for rectal cancer.
     BMC Cancer. 2017;17:325.
     PubMed     Text format     Abstract available
     
     
     April 2017
223. LELONG B, de Chaisemartin C, Meillat H, Cournier S, et al
     A multicentre randomised controlled trial to evaluate the efficacy, morbidity and functional outcome of endoscopic transanal proctectomy versus laparoscopic proctectomy for low-lying rectal cancer (ETAP-GRECCAR 11 TRIAL): rationale and design.
     BMC Cancer. 2017;17:253.
     PubMed     Text format     Abstract available
     
     
     March 2017
224. LI X, Lu H, Xu K, Wang H, et al
     Negative lymph node count is an independent prognostic factor for patients with rectal cancer who received preoperative radiotherapy.
     BMC Cancer. 2017;17:227.
     PubMed     Text format     Abstract available
     
     
     
225. BERNTSEN S, Aaronson NK, Buffart L, Borjeson S, et al
     Design of a randomized controlled trial of physical training and cancer (Phys-Can) - the impact of exercise intensity on cancer related fatigue, quality of life and disease outcome.
     BMC Cancer. 2017;17:218.
     PubMed     Text format     Abstract available
     
     
     
226. CERVANTES-MADRID D, Wettergren Y, Falk P, Lundholm K, et al
     DNA alterations in Cd133+ and Cd133- tumour cells enriched from intra-operative human colon tumour biopsies.
     BMC Cancer. 2017;17:219.
     PubMed     Text format     Abstract available
     
     
     
227. FENG YR, Jin J, Ren H, Wang X, et al
     Patients with pathological stage N2 rectal cancer treated with early adjuvant chemotherapy have a lower treatment failure rate.
     BMC Cancer. 2017;17:182.
     PubMed     Text format     Abstract available
     
     
     
228. FORZATI F, De Martino M, Esposito F, Sepe R, et al
     miR-155 is positively regulated by CBX7 in mouse embryonic fibroblasts and colon carcinomas, and targets the KRAS oncogene.
     BMC Cancer. 2017;17:170.
     PubMed     Text format     Abstract available
     
     
     February 2017
229. BRUNET J, Burke S, Grocott MP, West MA, et al
     The effects of exercise on pain, fatigue, insomnia, and health perceptions in patients with operable advanced stage rectal cancer prior to surgery: a pilot trial.
     BMC Cancer. 2017;17:153.
     PubMed     Text format     Abstract available
     
     
     
230. SINGH VP, Katta S, Kumar S
     WD-repeat protein WDR13 is a novel transcriptional regulator of c-Jun and modulates intestinal homeostasis in mice.
     BMC Cancer. 2017;17:148.
     PubMed     Text format     Abstract available
     
     
     
231. WEYN C, Van Raemdonck S, Dendooven R, Maes V, et al
     Clinical performance evaluation of a sensitive, rapid low-throughput test for KRAS mutation analysis using formalin-fixed, paraffin-embedded tissue samples.
     BMC Cancer. 2017;17:139.
     PubMed     Text format     Abstract available
     
     
     
232. PAHLE J, Menzel L, Niesler N, Kobelt D, et al
     Rapid eradication of colon carcinoma by Clostridium perfringens Enterotoxin suicidal gene therapy.
     BMC Cancer. 2017;17:129.
     PubMed     Text format     Abstract available
     
     
     
233. MEDENWALD D, Vordermark D, Dietzel CT
     Cancer mortality in former East and West Germany: a story of unification?
     BMC Cancer. 2017;17:94.
     PubMed     Text format     Abstract available
     
     
     January 2017
234. STEVENSON HL, Prats MM, Sasatomi E
     Chemotherapy-induced Sinusoidal Injury (CSI) score: a novel histologic assessment of chemotherapy-related hepatic sinusoidal injury in patients with colorectal liver metastasis.
     BMC Cancer. 2017;17:35.
     PubMed     Text format     Abstract available
     
     
     December 2016
235. YEDID N, Kalma Y, Malcov M, Amit A, et al
     The effect of a germline mutation in the APC gene on beta-catenin in human embryonic stem cells.
     BMC Cancer. 2016;16:952.
     PubMed     Text format     Abstract available
     
     
     November 2016
236. ZHANG J, Ren J, Wei J, Chong CC, et al
     Alternative splicing of estrogen receptor alpha in hepatocellular carcinoma.
     BMC Cancer. 2016;16:926.
     PubMed     Text format     Abstract available
     
     
     
237. STEPPELER C, Sodring M, Paulsen JE
     Colorectal Carcinogenesis in the A/J Min/+ Mouse Model is Inhibited by Hemin, Independently of Dietary Fat Content and Fecal Lipid Peroxidation Rate.
     BMC Cancer. 2016;16:832.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: